- Posts by Cara S. Donels
Senior AssociateCara’s practice focuses on intellectual property litigation and advice, with an emphasis on the life sciences field.
The U.S. Supreme Court recently issued its decision in Amgen Inc. v. Sanofi; a decision long-awaited by patent practitioners. In its decision, the Court unanimously held that several of Amgen’s patent claims to a class of antibodies were invalid for lack of enablement.